Article
Role of T2 inflammation biomarkers in severe asthma.
Current opinion in pulmonary medicine - 1 Jan 2016
Parulekar Amit D, Diamant Zuzana, Hanania Nicola A
Abstract excerpt
PURPOSE OF REVIEW: Severe asthma is a heterogeneous syndrome. Classification of asthma into phenotypes and endotypes can improve understanding and treatment of the disease. Identification and utilization of biomarkers, particularly those linked to T2 inflammation, can help group patients into phenotypes, predict those who will respond to a specific therapy, and assess the response to treatment. RECENT FINDINGS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
